BlackRock Fund Advisors’s Albany Molecular Research Inc AMRI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$48.8M	Buy	2,599,221 +359,629	+16%	+$6.11M	0.01%	1701
2016 Q3	$37M	Buy	2,239,592 +39,317	+2%	+$582K	0.01%	1775
2016 Q2	$29.6M	Buy	2,200,275 +72,249	+3%	+$1.05M	0.01%	1818
2016 Q1	$32.5M	Buy	2,128,026 +17,274	+0.8%	+$271K	0.01%	1711
2015 Q4	$41.9M	Sell	2,110,752 -22,764	-1%	-$433K	0.01%	1591
2015 Q3	$37.2M	Buy	2,133,516 +236,473	+12%	+$4.81M	0.01%	1608
2015 Q2	$38.4M	Buy	1,897,043 +57,894	+3%	+$1.12M	0.01%	1701
2015 Q1	$32.4M	Buy	1,839,149 +104,831	+6%	+$1.79M	0.01%	1794
2014 Q4	$28.2M	Buy	1,734,318 +105,970	+7%	+$1.94M	0.01%	1856
2014 Q3	$35.9M	Buy	1,628,348 +109,289	+7%	+$2.24M	0.01%	1572
2014 Q2	$30.6M	Buy	1,519,059 +484,445	+47%	+$8.21M	0.01%	1744
2014 Q1	$19.2M	Buy	1,034,614 +18,488	+2%	+$255K	0.01%	2025
2013 Q4	$10.2M	Buy	1,016,126 +4,879	+0.5%	+$59K	﹤0.01%	2374
2013 Q3	$13M	Buy	1,011,247 +125,175	+14%	+$1.54M	﹤0.01%	2204
2013 Q2	$10.5M	Buy	+886,072	New	+$9.6M	﹤0.01%	2239